Sarah Greenlee
Ionis Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Advanced biosensing and bioanalysis techniques, DNA and Nucleic Acid Chemistry, RNA modifications and cancer, Muscle Physiology and Disorders, Cellular transport and secretion
Most-Cited Works
- → Chemical modification of PS-ASO therapeutics reduces cellular protein-binding and improves the therapeutic index(2019)315 cited
- → Potent and Selective Antisense Oligonucleotides Targeting Single-Nucleotide Polymorphisms in the Huntington Disease Gene / Allele-Specific Silencing of Mutant Huntingtin(2011)289 cited
- → Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice(2017)97 cited
- → Inhaled ENaC antisense oligonucleotide ameliorates cystic fibrosis-like lung disease in mice(2017)86 cited
- → Elucidation of the Biotransformation Pathways of a Galnac3-conjugated Antisense Oligonucleotide in Rats and Monkeys(2016)57 cited
- → Metabolism and Disposition of Volanesorsen, a 2′-O-(2 methoxyethyl) Antisense Oligonucleotide, Across Species(2019)50 cited
- → Mapping, Genetic Isolation, and Characterization of Genetic Loci That Determine Resistance to Atherosclerosis in C3H Mice(2007)41 cited
- → Investigation into the Mechanism(s) That Leads to Platelet Decreases in Cynomolgus Monkeys During Administration of ISIS 104838, a 2ʹ-MOE-Modified Antisense Oligonucleotide(2018)37 cited
- → Unique O-Methoxyethyl Ribose-DNA Chimeric Oligonucleotide Induces an Atypical Melanoma Differentiation-Associated Gene 5-Dependent Induction of Type I Interferon Response(2012)30 cited
- → Bioanalysis Considerations on the Pharmacokinetic Evaluation of Antisense Therapeutics(2019)27 cited